Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22976 |
MFZ 10-7
|
Others; GluR | Neuroscience; Others |
MFZ 10-7 是 mGluR5 的负变构调节剂。 | |||
T14767 |
BP 897 hydrochloride
|
Dopamine Receptor | GPCR/G Protein; Neuroscience |
BP 897 hydrochloride 是有效的部分多巴胺 D3受体激动剂和弱 D2受体拮抗剂,在多巴胺 D3 受体 (Ki=0.92 nM) 上显示出高亲和力,而在 D2 受体上显示出 70 倍的低亲和力 (Ki=61 nM)。它表现出对可卡因寻求行为的选择性抑制。 | |||
T39161 |
Ro60-0175
Ro60-0175 |
5-HT Receptor | GPCR/G Protein; Neuroscience |
Ro60-0175 是 5- 羟色胺 2B (5-HT2B) 和 5- 羟色胺 2C (5-HT2C) 血清素受体亚型的选择性激动剂,常用富马酸盐形式。 它具有 5- 羟色胺 2B 受体激动剂和 5- 羟色胺 2C 受体激动剂的作用。 | |||
T9100 |
BP 897
2-Naphthalenecarboxamide, N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]- |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
BP 897 (2-Naphthalenecarboxamide, N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-) 是一种有效的部分多巴胺D3受体激动剂和弱D2受体拮抗剂,在多巴胺 D3 受体(Ki=0.92 nM) 上显示出高亲和力,而在 D2 受体上显示出 70 倍的低亲和力 (Ki=61 nM)。它表现出对可卡因寻求行为的选择性抑制。 | |||
T26807 |
Bifeprunox Mesylate
Bifeprunox,DU 127090,DU-127090,DU127090 |
||
Bifeprunox is a partial dopamine and serotonin agonist potentially for the treatment of schizophrenia. Bifeprunox suppresses in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation. Bifeprunox influences nicotine-seek | |||
T16507 |
PF-5006739
|
Casein Kinase | Metabolism; Stem Cells |
PF-5006739 is an effective and selective inhibitor of CK1δ/ε (IC50s: 3.9 nM and 17.0 nM, respectively). PF-5006739 is a potential therapeutic agent for a range of psychiatric disorders with low nanomolar in vitro potency for CK1δ/ε and high kinome selecti |